A detailed history of New York State Common Retirement Fund transactions in Dexcom Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 218,666 shares of DXCM stock, worth $17.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
218,666
Previous 307,392 28.86%
Holding current value
$17.5 Million
Previous $34.9 Million 57.94%
% of portfolio
0.02%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$64.0 - $116.06 $5.68 Million - $10.3 Million
-88,726 Reduced 28.86%
218,666 $14.7 Million
Q2 2024

Jul 31, 2024

BUY
$110.31 - $140.45 $609,131 - $775,564
5,522 Added 1.83%
307,392 $34.9 Million
Q1 2024

May 07, 2024

SELL
$114.22 - $140.1 $17.7 Million - $21.7 Million
-154,689 Reduced 33.88%
301,870 $41.9 Million
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $9.08 Million - $14.9 Million
120,236 Added 35.75%
456,559 $56.7 Million
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $5.15 Million - $8.25 Million
-59,817 Reduced 15.1%
336,323 $31.4 Million
Q2 2023

Aug 07, 2023

SELL
$112.47 - $130.98 $137,100 - $159,664
-1,219 Reduced 0.31%
396,140 $50.9 Million
Q1 2023

May 02, 2023

SELL
$104.0 - $122.92 $1.39 Million - $1.64 Million
-13,380 Reduced 3.26%
397,359 $46.2 Million
Q4 2022

Jan 30, 2023

BUY
$84.98 - $122.67 $244,572 - $353,044
2,878 Added 0.71%
410,739 $46.5 Million
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $799,537 - $986,252
-10,472 Reduced 2.5%
407,861 $32.8 Million
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $21.1 Million - $41.2 Million
310,380 Added 287.51%
418,333 $31.2 Million
Q1 2022

May 05, 2022

SELL
$94.08 - $130.2 $1.23 Million - $1.7 Million
-13,057 Reduced 10.79%
107,953 $55.2 Million
Q4 2021

Feb 02, 2022

SELL
$129.87 - $162.82 $1.08 Million - $1.36 Million
-8,344 Reduced 6.45%
121,010 $65 Million
Q3 2021

Nov 02, 2021

BUY
$106.71 - $143.18 $62,852 - $84,333
589 Added 0.46%
129,354 $70.7 Million
Q2 2021

Aug 02, 2021

SELL
$80.99 - $107.93 $4.98 Million - $6.63 Million
-61,461 Reduced 32.31%
128,765 $55 Million
Q1 2021

May 11, 2021

SELL
$84.79 - $104.74 $1.93 Million - $2.38 Million
-22,760 Reduced 10.69%
190,226 $68.4 Million
Q4 2020

Feb 08, 2021

SELL
$78.0 - $104.5 $297,180 - $398,145
-3,810 Reduced 1.76%
212,986 $78.7 Million
Q3 2020

Nov 05, 2020

SELL
$95.51 - $112.95 $2.49 Million - $2.95 Million
-26,086 Reduced 10.74%
216,796 $89.4 Million
Q2 2020

Aug 07, 2020

SELL
$62.68 - $105.34 $4.43 Million - $7.45 Million
-70,720 Reduced 22.55%
242,882 $98.5 Million
Q1 2020

May 06, 2020

BUY
$47.79 - $75.63 $448,031 - $709,031
9,375 Added 3.08%
313,602 $84.4 Million
Q4 2019

Feb 05, 2020

SELL
$36.62 - $57.29 $893,784 - $1.4 Million
-24,407 Reduced 7.43%
304,227 $66.5 Million
Q3 2019

Nov 07, 2019

BUY
$35.53 - $43.8 $77,526 - $95,571
2,182 Added 0.67%
328,634 $49 Million
Q2 2019

Aug 09, 2019

BUY
$27.84 - $38.92 $31,514 - $44,057
1,132 Added 0.35%
326,452 $48.9 Million
Q1 2019

May 08, 2019

SELL
$28.07 - $38.18 $458,214 - $623,250
-16,324 Reduced 4.78%
325,320 $38.7 Million
Q4 2018

Feb 08, 2019

SELL
$26.99 - $37.37 $208,335 - $288,459
-7,719 Reduced 2.21%
341,644 $40.9 Million
Q3 2018

Nov 07, 2018

SELL
$23.35 - $36.72 $693,144 - $1.09 Million
-29,685 Reduced 7.83%
349,363 $50 Million
Q2 2018

Aug 10, 2018

SELL
$17.54 - $25.22 $200,482 - $288,264
-11,430 Reduced 2.93%
379,048 $36 Million
Q1 2018

May 10, 2018

BUY
$13.06 - $18.54 $823,367 - $1.17 Million
63,045 Added 19.25%
390,478 $29 Million
Q4 2017

Feb 13, 2018

SELL
$11.12 - $15.38 $1.16 Million - $1.6 Million
-103,939 Reduced 24.09%
327,433 $18.8 Million
Q3 2017

Nov 06, 2017

SELL
$11.36 - $18.98 $903,244 - $1.51 Million
-79,511 Reduced 15.56%
431,372 $21.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
510,883
510,883 $37.4 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.